---
title: "Fuan Pharmaceutical Announcement on the Implementation of the 2025 Half-Year Equity Distribution Plan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/257680683.md"
description: "Fuan Pharmaceutical Co., Ltd. announced the 2025 semi-annual equity distribution plan on September 15. A cash dividend of 0.2 yuan will be distributed for every 10 shares, with a total distribution amount of 23,794,247.64 yuan. The equity registration date is September 24, and the ex-dividend date is September 25. The distribution is for all registered shareholders, and the cash dividend will be credited on September 25"
datetime: "2025-09-17T08:31:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257680683.md)
  - [en](https://longbridge.com/en/news/257680683.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257680683.md)
generator: "portal-rs"
---

# Fuan Pharmaceutical Announcement on the Implementation of the 2025 Half-Year Equity Distribution Plan

Fuan Pharmaceutical Co., Ltd. announced its 2025 semi-annual equity distribution plan, which was approved at the extraordinary general meeting of shareholders on September 15. Based on a total share capital of 1,189,712,382 shares, a cash dividend of RMB 0.2 will be distributed for every 10 shares, totaling RMB 23,794,247.64, with no bonus shares or capital increase. The record date for the distribution is September 24, and the ex-dividend date is September 25. The distribution will be made to all shareholders registered on the books. The cash dividends for A-share shareholders will be credited on September 25 through the China Securities Depository and Clearing Corporation Limited Shenzhen Branch, while shareholder Wang Tianxiang will receive the cash dividends directly from the company. The company assumes legal responsibilities related to the direct distribution. For consultation and reference documents, please see the announcement

### Related Stocks

- [300194.CN](https://longbridge.com/en/quote/300194.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [FOCUS-Green giant: How Taylor Farms became a top salad supplier before US diarrhea outbreak](https://longbridge.com/en/news/296469939.md)
- [Alpha Entrepreneurial Partners Investment TGV takes 3.03% stake in q.beyond voting rights](https://longbridge.com/en/news/296450706.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**